Evaluation of herbal compound containing Anacyclus pyrethrum, Senna, Ferrula asafoetida and Terminalia chebula in COVID19

INTERVENTION: Intervention group: In addition to the standard treatment (200 mg Hydroxychloroquine tablets or two 250 mg Chloroquine phosphate tablets), herbal tablets containing Anacyclus pyrethrum, Senna, Ferrula asafoetida and Terminalia chebula will be taken in three tablets three times a day for 7 to 14 days.. CONDITION: COVID19. ; COVID‐19 U07.1 PRIMARY OUTCOME: Decreasing duration of symptoms presence. Timepoint: During and at the end of the study. Method of measurement: Based on the date of hospitalization and the date of dissolving of fever and improving of respiratory symptoms including dyspenea, cough and improving of O2 saturation during daily history taking and physical exams. Decreasing hospital stay days. Timepoint: At the end of the study. Method of measurement: Based on the date of hospitalization and discharge from the hospital. Hospital care and treatment costs. Timepoint: At the end of the study. Method of measurement: Based on patients' financial records (hospital stay days and etc.). INCLUSION CRITERIA: Age: more than 18 Lab Analysis and CT‐scan Patient consent The severity of the disease: mild to moderate